Article detail · 2021
Diversity in Serine/Threonine Protein Kinase-4 Deficiency and Review of the Literature
Journal
The Journal of Allergy and Clinical Immunology: In PracticeISSN 2213-2198
The ISSN points to another catalog journal; the name is from the YÖKSİS record.
YÖKSİS
OpenAlex
SJR Q1
JCR Q1
Citations 35
Percentile 83.5%
FWCI 1.66
- Year
- 2021
- Type
- article
Data source split
- YÖKSİS YÖKSİS article record
- YÖKSİS venue The Journal of Allergy and Clinical Immunology: In Practice
- Catalog match (ISSN) Journal of Allergy and Clinical Immunology: In Practice
- OpenAlex OpenAlex enrichment (abstract, citations, topics)
Abstract
Abstract not compiled yet; it will appear after the DergiPark / OpenAlex queue runs.
Topics
Citations
OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.
35 citations
OpenAlex cited_by_count (cache / database)
26 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).
- A Stk4-Foxp3–NF-κB p65 transcriptional complex promotes T reg cell activation and homeostasis 2022
- A Stk4-Foxp3–NF-κB p65 transcriptional complex promotes T reg cell activation and homeostasis 2022
- A Stk4-Foxp3–NF-κB p65 transcriptional complex promotes T reg cell activation and homeostasis 2022
- Hematopoietic stem cell transplantation in serine/threonine kinase 4 (STK4) deficiency: Report of two cases and literature review 2023
- Hematopoietic stem cell transplantation in serine/threonine kinase 4 (STK4) deficiency: Report of two cases and literature review 2022
- Cutaneous Findings in Inborn Errors of Immunity: An Immunologists Perspective 2023
- Cutaneous Findings in Inborn Errors of Immunity: An Immunologists Perspective 2023
- Inborn errors of immunity-related immunological mechanisms and pharmacological therapy alternatives in periodontitis. 2025
- Inborn errors of immunity-related immunological mechanisms and pharmacological therapy alternatives in periodontitis 2025
- A single center experience on PI3K/AKT/MTOR signaling defects: Towards pathogenicity assessment for four novel defects. 2024